The abstract is read at the publisher; the summary is JClub's.
Small-molecule stabilization of human GITRL preserves membrane residency and enables physiological, bidirectional GITR signaling that expands cytotoxic CD8 T cells and depletes intratumoral regulatory T cells in humanized GITR/GITRL double-knock-in mice with syngeneic tumors.
- Why it matters: Agonistic GITR antibodies have failed clinically, suggesting receptor-targeted TNF superfamily agonism is limited by non-physiological receptor clustering and signaling context.
- What they did: The authors stabilized trimeric human GITRL with a small molecule, then tested signaling and immune effects in humanized GITR/GITRL double-knock-in mice bearing syngeneic tumors and in patient-derived tumor explants.
- The result: GITRL stabilization activates APCs, restructures tumor immune spatial architecture, and reactivates suppressed CD8 T cells in an APC-dependent manner, supporting ligand stabilization as a distinct therapeutic framework.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.